Zacks Research Issues Negative Forecast for Moderna Earnings
Moderna, Inc. (NASDAQ:MRNA – Free Report) – Stock analysts at Zacks Research decreased their Q2 2025 earnings per share estimates for shares of Moderna in a note issued to investors on Wednesday, May 21st. Zacks Research analyst S. Ganoria now expects that the company will post earnings per share of ($3.26) for the quarter, down […]
Moderna, Inc. (NASDAQ:MRNA – Free Report) – Stock analysts at Zacks Research decreased their Q2 2025 earnings per share estimates for shares of Moderna in a note issued to investors on Wednesday, May 21st. Zacks Research analyst S. Ganoria now expects that the company will post earnings per share of ($3.26) for the quarter, down […]
